Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis
F Hadi, S Kashefinejad, L Kamalzadeh… - BMC Pharmacology and …, 2021 - Springer
Background Obsessive-compulsive disorder (OCD) is among the most disabling
neuropsychiatric conditions characterized by the presence of repetitive intrusive thoughts …
neuropsychiatric conditions characterized by the presence of repetitive intrusive thoughts …
The state of psychiatric research in the Asia Pacific region
Introduction This study aims to review recent scientific publications and research output in
the field of psychiatry, from a series of countries in the Asia‐Pacific region (Australia, India …
the field of psychiatry, from a series of countries in the Asia‐Pacific region (Australia, India …
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind …
Background Medications currently recommended for the treatment of Obsessive-Compulsive
Disorder (OCD) usually decrease the severity of the symptoms by 20–30%; however, 40 …
Disorder (OCD) usually decrease the severity of the symptoms by 20–30%; however, 40 …
Safety and side effects of psychotropic medications
R de Filippis, M Solerdelcoll, M Shalbafan - Frontiers in Psychiatry, 2023 - frontiersin.org
In the last few decades psychopharmacology has witnessed an incredible development in
terms of efficacy, safety and number of options available for the treatment and management …
terms of efficacy, safety and number of options available for the treatment and management …
[PDF][PDF] Designing a deep learning hybrid using CNN and Inception V3 transfer learning to detect the aggression level of deep obsessive compulsive disorder in …
The usage of Artificial intelligence in medical arena has proved to be a game changer in the
detection and diagnosis of several medical conditions. In the current digital era, children with …
detection and diagnosis of several medical conditions. In the current digital era, children with …
[HTML][HTML] Cognitive rehabilitation for adult patients with obsessive-compulsive disorder: A systematic review of randomized controlled trials
F Bakizadeh, S Mokhtari, F Saeed… - Basic and Clinical …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction: Obsessive-compulsive disorder (OCD) is a disabling mental condition. Many
studies have shown that OCD patients have cognitive deficits in various aspects of their …
studies have shown that OCD patients have cognitive deficits in various aspects of their …
Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis
Objectives The augmentation of serotonin reuptake inhibitors (SRIs) can be achieved by add‐
on therapy with different pharmacological agents in obsessive–compulsive disorder (OCD) …
on therapy with different pharmacological agents in obsessive–compulsive disorder (OCD) …
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled …
M Shokrani, S Askari, N Eissazade, SV Shariat… - BMC psychiatry, 2023 - Springer
Abstract Background As 40–60% of the patients with obsessive-compulsive disorder (OCD)
do not adequately respond to the first-line treatment, finding an effective second-line …
do not adequately respond to the first-line treatment, finding an effective second-line …
The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of …
S Eghdami, N Eissazade, M Heidari Mokarar… - Frontiers in …, 2024 - frontiersin.org
Background Obsessive-compulsive disorder (OCD) ranks as the fourth most prevalent
psychiatric disorder, with selective serotonin reuptake inhibitors (SSRIs) as its mainstay …
psychiatric disorder, with selective serotonin reuptake inhibitors (SSRIs) as its mainstay …
Serotonin 3 receptor antagonists for obsessive-compulsive disorder: A systematic review and pairwise meta-analysis
S Hamanaka, T Kishi, K Sakuma, Y Nishii… - Journal of Psychiatric …, 2023 - Elsevier
The benefits of serotonin 3 receptor antagonists (5-HT3R-As) in obsessive-compulsive
disorder (OCD) treatment remain unclear. Thus, this study aimed to perform a systematic …
disorder (OCD) treatment remain unclear. Thus, this study aimed to perform a systematic …